GSK plc Profile Avatar - Palmy Investing

GSK plc

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United …
Drug Manufacturers - General
GB, Brentford [HQ]

Balance Sheet

15 Sheets · Starting from 2023
In Million GBP. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
42,862.00 42,052.00 41,080.00 41,475.00 42,086.00 40,651.00 53,446.00 59,081.00 56,381.00 58,066.00 79,692.00 80,431.00 79,103.00 60,146.00 59,005.00
Current
17,570.00 16,036.00 16,167.00 13,692.00 15,227.00 14,678.00 16,587.00 16,711.00 15,907.00 16,927.00 19,491.00 20,247.00 18,674.00 20,769.00 18,644.00
Non Current
25,292.00 26,016.00 24,913.00 27,783.00 26,859.00 25,973.00 36,859.00 42,370.00 40,474.00 41,139.00 60,201.00 60,184.00 60,429.00 39,377.00 40,361.00
Liabilities
32,120.00 32,307.00 32,253.00 34,728.00 34,274.00 35,715.00 44,568.00 54,118.00 52,892.00 54,394.00 61,335.00 59,623.00 57,761.00 50,050.00 46,210.00
Current
12,118.00 12,616.00 15,010.00 13,815.00 13,677.00 13,295.00 13,417.00 19,001.00 26,569.00 22,491.00 24,050.00 22,148.00 23,670.00 22,810.00 21,068.00
Non Current
20,002.00 19,691.00 17,243.00 20,913.00 20,597.00 22,420.00 31,151.00 35,117.00 26,323.00 31,903.00 37,285.00 37,475.00 34,091.00 27,240.00 25,142.00
Equity
10,742.00 9,745.00 8,827.00 6,747.00 7,812.00 4,936.00 8,878.00 4,963.00 3,489.00 3,672.00 18,357.00 20,808.00 21,342.00 10,096.00 12,795.00
Stockholders' Equity
10,005.00 8,887.00 8,032.00 5,810.00 6,997.00 4,263.00 5,114.00 1,124.00 -68.00 4,360.00 11,984.00 14,587.00 15,055.00 10,598.00 13,347.00
Retained Earnings
6,321.00 4,779.00 3,370.00 652.00 913.00 -2,074.00 -1,397.00 -5,392.00 -6,477.00 -2,137.00 5,109.00 6,755.00 7,944.00 4,363.00 7,239.00
Common Stock
1,416.00 1,418.00 1,387.00 1,349.00 1,336.00 1,339.00 1,340.00 1,342.00 1,343.00 1,345.00 1,346.00 1,346.00 1,347.00 1,347.00 1,348.00
Preferred Stock
- - - - - - - - - - - - - - - - - - - - - - - - - - 48.00 - -
Profit
5,531.00 1,634.00 5,261.00 4,565.00 5,436.00 2,756.00 8,422.00 912.00 1,532.00 3,623.00 4,645.00 5,749.00 4,385.00 4,921.00 4,928.00
Dividends
-3,092.00 -3,205.00 -3,406.00 -3,814.00 -3,680.00 -3,843.00 -3,874.00 -4,850.00 -3,906.00 -3,927.00 -3,953.00 -3,977.00 -3,999.00 -3,467.00 -2,247.00
Minority Interest
737.00 858.00 795.00 937.00 815.00 673.00 3,764.00 3,839.00 3,557.00 -688.00 6,373.00 6,221.00 6,287.00 -502.00 -552.00
Other Stockholders' Equity
2,268.00 2,690.00 3,275.00 3,809.00 2,009.00 2,896.00 3,592.00 4,517.00 4,468.00 4,779.00 4,888.00 4,935.00 5,122.00 4,888.00 3,163.00
Loss Other Compr. Income
- - - - - - - - 2,739.00 2,102.00 1,579.00 657.00 598.00 373.00 641.00 1,551.00 642.00 -48.00 1,597.00
End of GSK's Analysis
CIK: 1131399 CUSIP: 37733W204 ISIN: US37733W2044 LEI: - UEI: -
Secondary Listings